9781632410153 t fc

ISBN : 9781632410153

Publisher :   haylemedical

Language :   English

Category :   Oncology

Publication Year :   2015

Price : USD 90.00

Description :  Chronic Lymphocytic Leukemia (CLL) is a disease which has a variable course, and survival rates range from months to decades. It is evident that clinical heterogeneity represents biologic variety with two main subtypes in terms of cellular multiplication, clinical aggressiveness and predictability. As CLL progresses, irregular hematopoiesis leads to pancytopenia and decreased immunoglobulin creation, followed by nonspecific symptoms such as fatigue or malaise. A cure is tough to find in normal cases and postponed treatment (until symptoms develop) is aimed at lengthening life and eliminating symptoms. Experts are playing a crucial role in studying CLL's main source and the role of genetics in the development of this disorder. Research programs are devoted towards comprehending the essential mechanisms underlying CLL with the hope of enhancing treatment options. The book entails a detailed analysis of CLL prognosis and therapy.

Author/Editor :  Matthew Griffin

Author's Description :  Matthew Griffin is an MD and a PhD living in Berlin, Germany. He is a member of several medical societies. He has written over 200 articles, journals, medical works and books in the field of leukemia. Matthew volunteered for various health missions, for the betterment of the society. His vast expertise is an inspiration for many professionals across the globe. Currently he is a professor in a German University, helping medical students and young doctors.